SMTL ID : 1udu.1

Crystal structure of Human Phosphodiesterase 5 complexed with tadalafil(Cialis)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.83 Å

Oligo State

homo-dimer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.81, H.117, D.118, D.228 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.81, A:H.117, A:D.118 ZN.4: 5 residues within 4Å: Chain B: H.81, H.117, D.118, D.228 Ligands: MG.5 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:H.81, B:H.117, B:D.118, B:D.228, B:D.228

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: D.118, T.187 No protein-ligand interaction detected (PLIP) MG.5: 3 residues within 4Å: Chain B: D.118, T.187 Ligands: ZN.4 No protein-ligand interaction detected (PLIP)

2 x CIA: 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE(Non-covalent)

CIA.3: 12 residues within 4Å: Chain A: Y.76, S.127, I.242, V.246, A.247, F.250, F.251, L.268, I.277, M.280, Q.281, F.284 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.76, A:I.242, A:V.246, A:V.246, A:F.250, A:F.250, A:L.268, A:M.280, A:Q.281, A:F.284 Hydrogen bonds: A:Q.281, A:Q.281 CIA.6: 14 residues within 4Å: Chain B: Y.76, A.231, I.232, Q.239, I.242, V.246, A.247, F.250, F.251, L.268, I.277, M.280, Q.281, F.284 12 PLIP interactions: 12 interactions with chain B Hydrophobic interactions: B:Y.76, B:A.231, B:I.232, B:I.242, B:V.246, B:F.250, B:L.268, B:M.280, B:Q.281, B:F.284 Hydrogen bonds: B:Q.281, B:Q.281

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sung, B.-J. et al., Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature (2003)

Release Date

2004-05-11

Peptides

cGMP-specific 3',5'-cyclic phosphodiesterase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

cGMP-specific 3',5'-cyclic phosphodiesterase

Related Entries With Identical Sequence